Advanced Enzyme Technologies Ltd
Recommended a Final Dividend - 67.5% i.e. Rs. 1.35/- per Equity Share on the face value of Rs. 2 each for the Financial Year 2025-26, Subject to the approval of the Shareholders at the ....
DIVIDEND
▲ Positive Development
LOW RISK
📅 Filed on BSE: 09 May 2026, 01:55 PM IST · BSE ID: 7339f8c2-2022-4ed0-b6a2-02bf4132a7e2
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board recommended a ₹ 1.35 per share final dividend, while deferring an interim dividend for future strategic options.
🤖 AI Summary
- Board recommended a final dividend of ₹ 1.35 per Equity Share (67.5%) for FY2025-26
- Dividend is subject to shareholder approval at the upcoming 37th Annual General Meeting
- Interim dividend deferred to preserve capital for evaluating strategic avenues/corporate actions
- Re-appointment of Mr. Mukund Madhusudan Kabra as Whole Time Director for 5 years approved
- Appointment of Mr. Pradip Bhailal Shah as Independent Director for 5 years approved
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹ 1.35/-
Final Dividend Percentage
67.5%
Equity Share Face Value
₹ 2/-
🏢 How This Affects the Company
The recommendation of a final dividend will result in a cash outflow from the company upon approval and declaration by shareholders.
The re-appointment of Mr. Mukund Madhusudan Kabra as Whole Time Director maintains continuity in executive leadership for the next five years. The appointment of Mr. Pradip Bhailal Shah as an Additional Director (Independent) expands the Board's independent oversight.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must vote on the final dividend and director appointments at the ensuing 37th Annual General Meeting.
👤
Who Is Affected
Shareholders on record date, once intimated, will be eligible for the ₹ 1.35 per Equity Share final dividend if approved at the AGM.
🔍
Management Signal
Management intends to balance shareholder returns with capital preservation for future strategic growth initiatives.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Intimation of record date for final dividend entitlement
Announcement of the date for the 37th Annual General Meeting
Details of potential strategic avenues/corporate actions indicated by the Board
LOW RISK
The filing reports routine corporate actions, including dividend recommendation and director appointments.
💡 Investor Takeaway
Advanced Enzyme Technologies Board recommended a final dividend of ₹ 1.35 per Equity Share (67.5%) for FY2025-26. The Board also deferred an interim dividend to preserve capital for evaluating potential strategic avenues/corporate actions to maximize long-term shareholder value.
⚖️ Strengths & Concerns
✅ Positives
- Recommendation of a final dividend of ₹ 1.35 per Equity Share for FY2025-26 signals operational profitability and cash generation.
- Board's decision to preserve capital provides flexibility to evaluate strategic avenues maximizing long-term shareholder value.
⚠️ Concerns
- The deferral of an interim dividend, despite healthy financial position and robust liquidity, reduces immediate shareholder payout.
- All director appointments and the dividend are subject to shareholder approval at the 37th AGM, introducing a minor conditionality.
📅 Company Track Record
No previous filings context found for this company in available data.
Based on publicly available historical data. For context only.